http://www.kpmg.com/_layouts/feed.aspx?xsl=1&web=/Global/en/IssuesAndInsights/RSSFeeds&page=ea983344-29e5-4857-b475-2ccb3b0a2fe3&wp=61d25a0e-264a-46c3-940e-7a381bb280f9Keep up with new developments added to this site by subscribing to our Life Sciences feed.60http://www.kpmg.com/Global/en/IssuesAndInsights/ArticlesPublications/Press-releases/Pages/chris-stirling-global-chair-of-life-sciences.aspxKPMG today announced the appointment of Chris Stirling as Global Chair of KPMG's Life Sciences practice.Wed, 17 Oct 2012 05:00:31 GMThttp://www.kpmg.com/Global/en/IssuesAndInsights/ArticlesPublications/sustainable-insight/Pages/water-scarcity.aspxThis edition of Sustainable Insight explores how the world’s major businesses are approaching water scarcity via corporate responsibility and sustainability reporting.Fri, 26 Apr 2013 05:42:29 GMThttp://www.kpmg.com/Global/en/IssuesAndInsights/ArticlesPublications/Pages/risk-and-disclosure-in-the-global-pharmaceutical-industry.aspxKPMG analysis of Risk and Disclosure in the Global Pharmaceutical and Life Sciences Industry.Mon, 01 Oct 2012 08:50:19 GMThttp://www.kpmg.com/Global/en/IssuesAndInsights/ArticlesPublications/Pages/management-consulting-benchmarking.aspxThe report highlights that procurement functions need to extend their activities and take on a more strategic role within the organization.Wed, 20 Mar 2013 01:29:24 GMThttp://www.kpmg.com/Global/en/IssuesAndInsights/ArticlesPublications/Pages/the-convergence-evolution.aspxSince the financial crisis, companies are focused on GRC; despite pressures for change, companies still remain at the infancy stage of convergence.Mon, 01 Oct 2012 09:08:10 GMThttp://www.kpmg.com/Global/en/IssuesAndInsights/ArticlesPublications/Pages/building-business-value.aspxKPMG explores 10 sustainability megaforces set to impact business over the next 20 year.Fri, 08 Feb 2013 06:36:16 GMThttp://www.kpmg.com/Global/en/IssuesAndInsights/ArticlesPublications/Issues-monitor-pharmaceuticals/Pages/pharmaceuticals-february-2012.aspxIt highlights the benefits & challenges with the adoption of technologies targeted to build efficiency in sales and marketing.Mon, 01 Oct 2012 08:51:53 GMThttp://www.kpmg.com/Global/en/IssuesAndInsights/ArticlesPublications/Pages/going-social.aspxSocial media has become a business imperative with more than 70% of organizations operating around the world now active on social media.Mon, 01 Oct 2012 09:10:20 GMThttp://www.kpmg.com/Global/en/IssuesAndInsights/ArticlesPublications/Pages/designing-sustainability-strategies.aspxMember firms have joined forces with RobecoSAM to help the organizations capitalize on the commercial possibilities of sustainable business practices.Tue, 22 Jan 2013 11:52:32 GMThttp://www.kpmg.com/Global/en/IssuesAndInsights/ArticlesPublications/corporate-responsibility/Pages/Default.aspxKPMG International Corporate Responsibility Reporting Survey 2011 is one of the most comprehensive surveys of CR reporting trends ever published.Mon, 04 Feb 2013 12:59:03 GMThttp://www.kpmg.com/Global/en/IssuesAndInsights/ArticlesPublications/Pages/cloud-clarity.aspxThe 2011 survey examines three different perspectives with regard to the adoption of cloud and provides insight into the forces shaping the cloud market.Fri, 07 Dec 2012 02:05:28 GMThttp://www.kpmg.com/Global/en/IssuesAndInsights/ArticlesPublications/Pages/future-pharma.aspxThis paper explores some of the major challenges facing the pharmaceutical industry today and provides five strategies to accelerate industry transformation.Wed, 30 Jan 2013 14:39:42 GMThttp://www.kpmg.com/Global/en/IssuesAndInsights/ArticlesPublications/Pages/australias-climate-change-plan.aspxThis summary of Climate Change Plan report includes proposed carbon price mechanism – how it will work and key implications for business in Australia.Mon, 22 Apr 2013 23:35:41 GMThttp://www.kpmg.com/Global/en/IssuesAndInsights/ArticlesPublications/Pages/australias-climate-change-plan-summary.aspxThis document focuses on the major programs announced as part of The Australian Government's Climate Change Plan (the Plan).Mon, 22 Apr 2013 23:35:48 GMThttp://www.kpmg.com/Global/en/IssuesAndInsights/ArticlesPublications/Issues-monitor-pharmaceuticals/Pages/issues-monitor-pharmaceuticals-june-2011.aspxRising litigation costs for pharma industry are due to lawsuits & settlements, with huge impact on income & reputation of major industry players.Mon, 01 Oct 2012 09:12:52 GMT